UA82845C2 - Use of vasopeptidase inhibitors in the treatment of nephropathy - Google Patents

Use of vasopeptidase inhibitors in the treatment of nephropathy

Info

Publication number: UA82845C2
Authority: UA; Ukraine
Prior art keywords: diabetic; nephropathy; treatment; vasopeptidase inhibitors; syndome
Prior art date: 2002-06-28

Application number

UA2005000743A

Other languages

English (en)

Inventor

Wolfgang Linz

Marcus Bleich

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-28

Filing date

2003-06-13

Publication date

2008-05-26

2003-06-13 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2008-05-26 Publication of UA82845C2 publication Critical patent/UA82845C2/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

UA2005000743A 2002-06-28 2003-06-13 Use of vasopeptidase inhibitors in the treatment of nephropathy UA82845C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE2002129180 DE10229180A1 (de)	2002-06-28	2002-06-28	Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
PCT/EP2003/006276 WO2004002492A1 (en)	2002-06-28	2003-06-13	Use of vasopeptidase inhibitors in the treatment of nephropathy

Publications (1)

Publication Number	Publication Date
UA82845C2 true UA82845C2 (en)	2008-05-26

Family

ID=29795983

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA2005000743A UA82845C2 (en)	2002-06-28	2003-06-13	Use of vasopeptidase inhibitors in the treatment of nephropathy

Country Status (38)

Country	Link
US (2)	US6930103B2 (xx)
EP (1)	EP1519732B1 (xx)
JP (1)	JP4564354B2 (xx)
KR (1)	KR101072235B1 (xx)
CN (1)	CN100366254C (xx)
AR (1)	AR040343A1 (xx)
AT (1)	ATE548040T1 (xx)
AU (1)	AU2003280440B2 (xx)
BR (1)	BR0312250A (xx)
CA (1)	CA2490277C (xx)
CR (1)	CR7667A (xx)
CY (1)	CY1112905T1 (xx)
DE (1)	DE10229180A1 (xx)
DK (1)	DK1519732T3 (xx)
EC (1)	ECSP045513A (xx)
ES (1)	ES2383889T3 (xx)
HN (1)	HN2003000193A (xx)
HR (1)	HRP20041212B1 (xx)
IL (2)	IL165935A0 (xx)
MA (1)	MA27281A1 (xx)
MX (1)	MXPA04012230A (xx)
NO (1)	NO334811B1 (xx)
NZ (1)	NZ537480A (xx)
OA (1)	OA12871A (xx)
PA (1)	PA8576501A1 (xx)
PE (1)	PE20040582A1 (xx)
PL (1)	PL218070B1 (xx)
PT (1)	PT1519732E (xx)
RS (1)	RS52478B (xx)
RU (1)	RU2336080C2 (xx)
SI (1)	SI1519732T1 (xx)
SV (1)	SV2004001560A (xx)
TN (1)	TNSN04262A1 (xx)
TW (1)	TWI326215B (xx)
UA (1)	UA82845C2 (xx)
UY (1)	UY27869A1 (xx)
WO (1)	WO2004002492A1 (xx)
ZA (1)	ZA200409382B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2482546C2 (ru) *	2011-04-28	2013-05-20	Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг"	Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведений антител к с-концевому фрагменту рецептора ангиотензина ii

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5430145A (en) *	1990-10-18	1995-07-04	Merrell Dow Pharmaceuticals Inc.	Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
CA2053340C (en) *	1990-10-18	2002-04-02	Timothy P. Burkholder	Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
ATE138645T1 (de) *	1991-03-01	1996-06-15	Zeria Pharm Co Ltd	Indan-derivate als thromboxan-antagonisten
RU2098411C1 (ru) *	1991-08-02	1997-12-10	Иституто Лусо Фармако д Италия С.п.А.	Производные пиримидина, способ их получения, фармацевтическая композиция на их основе
ES2106112T3 (es) *	1991-09-27	1997-11-01	Merrell Pharma Inc	Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
WO1993016103A1 (en) *	1992-02-14	1993-08-19	Merrell Dow Pharmaceuticals Inc.	Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5484783A (en) *	1994-03-24	1996-01-16	Merrell Dow Pharmaceuticals Inc.	Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
ATE189392T1 (de) *	1994-03-24	2000-02-15	Merrell Pharma Inc	Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten
CA2224451A1 (en) *	1995-06-30	1997-01-23	Merck & Co., Inc.	Method of treating renal disease using an ace inhibitor and an aii antagonist
BR9612316A (pt)	1995-12-27	1999-07-13	Yoshitomi Pharmaceutical	Agente para profilaxia e tratamento de complicações diabéticas
RU2276997C2 (ru) *	1999-08-30	2006-05-27	Санофи-Авентис Дойчланд Гмбх	Применение ингибиторов ренин-ангиотензиновой системы для профилактики сердечно-сосудистых явлений
US6149915A (en)	1999-09-29	2000-11-21	Shiva Biomedical, Llc	Treatment of diabetic nephropathy and microalbuminuria
EP1381605B1 (en) *	2001-04-12	2005-01-12	Aventis Pharma Deutschland GmbH	Mercaptoacetylamide derivatives, a process for their preparation and their use
US20030040509A1 (en) *	2001-08-06	2003-02-27	Genomed, Llc	Methods and compositions for treating diseases associated with excesses in ACE

2002
- 2002-06-28 DE DE2002129180 patent/DE10229180A1/de not_active Ceased
2003
- 2003-06-13 JP JP2004516596A patent/JP4564354B2/ja not_active Expired - Fee Related
- 2003-06-13 WO PCT/EP2003/006276 patent/WO2004002492A1/en not_active Ceased
- 2003-06-13 BR BR0312250A patent/BR0312250A/pt not_active IP Right Cessation
- 2003-06-13 IL IL16593503A patent/IL165935A0/xx unknown
- 2003-06-13 UA UA2005000743A patent/UA82845C2/xx unknown
- 2003-06-13 PL PL372992A patent/PL218070B1/pl unknown
- 2003-06-13 AT AT03740247T patent/ATE548040T1/de active
- 2003-06-13 HR HRP20041212AA patent/HRP20041212B1/hr not_active IP Right Cessation
- 2003-06-13 KR KR1020047021259A patent/KR101072235B1/ko not_active Expired - Fee Related
- 2003-06-13 CN CNB038153491A patent/CN100366254C/zh not_active Expired - Fee Related
- 2003-06-13 MX MXPA04012230A patent/MXPA04012230A/es active IP Right Grant
- 2003-06-13 PT PT03740247T patent/PT1519732E/pt unknown
- 2003-06-13 EP EP20030740247 patent/EP1519732B1/en not_active Expired - Lifetime
- 2003-06-13 NZ NZ537480A patent/NZ537480A/en not_active IP Right Cessation
- 2003-06-13 ES ES03740247T patent/ES2383889T3/es not_active Expired - Lifetime
- 2003-06-13 RU RU2005102087A patent/RU2336080C2/ru not_active IP Right Cessation
- 2003-06-13 AU AU2003280440A patent/AU2003280440B2/en not_active Ceased
- 2003-06-13 DK DK03740247T patent/DK1519732T3/da active
- 2003-06-13 RS YUP100704 patent/RS52478B/sr unknown
- 2003-06-13 CA CA 2490277 patent/CA2490277C/en not_active Expired - Fee Related
- 2003-06-13 SI SI200332139T patent/SI1519732T1/sl unknown
- 2003-06-13 OA OA1200400333A patent/OA12871A/en unknown
- 2003-06-20 PE PE2003000623A patent/PE20040582A1/es not_active Application Discontinuation
- 2003-06-23 SV SV2003001560A patent/SV2004001560A/es not_active Application Discontinuation
- 2003-06-24 PA PA8576501A patent/PA8576501A1/es unknown
- 2003-06-26 US US10/607,521 patent/US6930103B2/en not_active Expired - Lifetime
- 2003-06-26 HN HN2003000193A patent/HN2003000193A/es unknown
- 2003-06-26 AR ARP030102293 patent/AR040343A1/es unknown
- 2003-06-26 TW TW92117352A patent/TWI326215B/zh not_active IP Right Cessation
- 2003-06-27 UY UY27869A patent/UY27869A1/es unknown
2004
- 2004-11-22 ZA ZA2004/09382A patent/ZA200409382B/en unknown
- 2004-12-08 MA MA27991A patent/MA27281A1/fr unknown
- 2004-12-22 IL IL16593504A patent/IL165935A/en not_active IP Right Cessation
- 2004-12-27 TN TNP2004000262A patent/TNSN04262A1/en unknown
- 2004-12-27 EC ECSP045513 patent/ECSP045513A/es unknown
2005
- 2005-01-25 NO NO20050425A patent/NO334811B1/no not_active IP Right Cessation
- 2005-01-28 CR CR7667A patent/CR7667A/es unknown
- 2005-04-01 US US11/096,790 patent/US7514423B2/en not_active Expired - Lifetime
2012
- 2012-05-30 CY CY20121100488T patent/CY1112905T1/el unknown

Also Published As

Publication number	Publication date
PA8576501A1 (es)	2004-02-07
SV2004001560A (es)	2004-02-26
DK1519732T3 (da)	2012-06-18
NZ537480A (en)	2005-11-25
TWI326215B (en)	2010-06-21
ECSP045513A (es)	2005-03-10
AR040343A1 (es)	2005-03-30
EP1519732B1 (en)	2012-03-07
RU2005102087A (ru)	2005-07-10
DE10229180A1 (de)	2004-01-29
UY27869A1 (es)	2003-12-31
NO334811B1 (no)	2014-06-02
PL218070B1 (pl)	2014-10-31
CA2490277C (en)	2011-11-01
TW200406214A (en)	2004-05-01
RS52478B (sr)	2013-02-28
BR0312250A (pt)	2005-04-26
KR20050013642A (ko)	2005-02-04
US6930103B2 (en)	2005-08-16
OA12871A (en)	2006-09-15
ATE548040T1 (de)	2012-03-15
CN100366254C (zh)	2008-02-06
PE20040582A1 (es)	2004-10-18
US20050171090A1 (en)	2005-08-04
JP4564354B2 (ja)	2010-10-20
JP2005533815A (ja)	2005-11-10
HRP20041212A2 (en)	2005-06-30
EP1519732A1 (en)	2005-04-06
KR101072235B1 (ko)	2011-10-12
WO2004002492A1 (en)	2004-01-08
HN2003000193A (es)	2004-10-27
IL165935A (en)	2010-12-30
TNSN04262A1 (en)	2007-03-12
ES2383889T3 (es)	2012-06-27
RU2336080C2 (ru)	2008-10-20
AU2003280440A1 (en)	2004-01-19
CN1665512A (zh)	2005-09-07
MXPA04012230A (es)	2005-02-25
CA2490277A1 (en)	2004-01-08
CY1112905T1 (el)	2016-04-13
MA27281A1 (fr)	2005-04-01
CR7667A (es)	2005-06-16
PL372992A1 (en)	2005-08-08
HRP20041212B1 (hr)	2013-06-30
RS100704A (sr)	2007-02-05
NO20050425L (no)	2005-01-25
ZA200409382B (en)	2006-01-25
SI1519732T1 (sl)	2012-05-31
AU2003280440B2 (en)	2009-07-16
HK1079435A1 (zh)	2006-04-07
US20040058911A1 (en)	2004-03-25
IL165935A0 (en)	2006-01-15
US7514423B2 (en)	2009-04-07
PT1519732E (pt)	2012-05-22

Publication	Publication Date	Title
GEP20125506B (en)	2012-04-25	Glucagon receptor antagonist compounds, compositions containing such compounds and use
WO2008011453A3 (en)	2009-04-16	SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLβ-HSD-1
EA011086B9 (ru)	2012-08-30	Производные пролина и их применение в качестве ингибиторов дипептидилпептидазы iv
MX2009012708A (es)	2009-12-08	Derivados de piridazinona.
UA95798C2 (ru)	2011-09-12	Производные циклогексилпиразоллактама как ингибиторы 11-бета-гидроксистероиддегидрогеназы 1
IL186566A0 (en)	2008-01-20	Substituted 2-amin0alkylth10-benzimidaz0les and use thereof for reducing blood sugar levels
DE602007007473D1 (en)	2010-08-12	11-beta-hydroxysteroid-dehydrogenase-1-hemmer
WO2008062376A3 (en)	2008-07-10	New process for the preparation of 2-imino-thiazolidin-4-one derivatives
MX2009005881A (es)	2009-06-12	Derivados de 2-(piperidin-4-il)-4-fenoxi o fenilamino-pirimidina como inhibidores de la transcriptasa inversa no nucleosida.
DE602007004324D1 (en)	2010-03-04	11-beta-hydroxysteroid-dehydrogenase-1-hemmer
TW200716648A (en)	2007-05-01	Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
UA89040C2 (ru)	2009-12-25	Замещенные глюкопиранозилом бензольные производные, лекарственное средство, которое содержит эти соединения
MX2007011023A (es)	2008-03-12	2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
MX2010003759A (es)	2010-04-21	Derivados de piridina utiles como activadores de glucocinasa.
TNSN08432A1 (en)	2010-04-14	Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
IL195256A0 (en)	2009-08-03	Compositions of r(+)and s(-)pramipexole and methods of using the same
TW200738729A (en)	2007-10-16	Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
MX2010003368A (es)	2010-04-30	Derivados de imidazol.
MX2008011633A (es)	2008-12-16	Aminoquinolonas como inhibidores de gsk-3.
MXPA04000891A (es)	2004-05-21	Nuevos derivados de acido vinilcarboxilico y su uso como antidiabeticos.
UA96759C2 (xx)	2011-12-12	ПОХІДНІ 2-АРИЛІНДОЛУ ЯК mPGES-1 ІНГІБІТОРИ$ПРОИЗВОДНЫЕ 2-АРИЛИНДОЛА КАК mPGES-1 ИНГИБИТОРЫ
TW200740787A (en)	2007-11-01	(6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones
MX2007006284A (es)	2007-06-15	Acidos biariloximetilarenocarboxilicos.
CA2659376C (en)	2014-10-14	2,4-diaminoquinazolines for spinal muscular atrophy
TW200407133A (en)	2004-05-16	Novel PPARα and PPARγ agonists